Proteintech Group
- Company typePrivate
- Founded2001
- HeadquartersRosamond, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Proteintech Group firmographics
Firmographics- Name
- Proteintech Group
- Legal name
- Proteintech Group, Inc.
- Website
- https://ptglab.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Proteintech Group industry classification
Industry- Product category
- Life Science Research Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Cytokines, Interferons & Immunomodulatory Proteins (HLAAAAAC), Therapeutic Peptides & Protein/Peptide Biologics (HLAAAAAH)
Keywords
Where Proteintech Group is headquartered
LocationHeadquarters
- HQ city
- Rosamond
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Proteintech Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Research Antibodies: Sale of primary and secondary antibodies for applications including Western Blot, Immunohistochemistry, Immunofluorescence, Flow Cytometry, and Immunoprecipitation. Products are sold directly via e-commerce and through distributor network.
- Recombinant Proteins: Sale of cytokines, growth factors, and fusion proteins including both research grade and cGMP grade for cell and gene therapy applications. HumanKine brand offers human cell-expressed proteins.
- ELISA Kits: Complete enzyme-linked immunosorbent assay kits including traditional and speedy formats for research diagnostics.
- Nanobody-based Reagents: Products from ChromoTek subsidiary including Nano-Traps, Chromobodies, and Spot-Tag systems for specialized immunoprecipitation and imaging applications.
- Custom Antibody Services: Full-service custom antibody development from antigen design through large-scale production, characterization, and conjugation.
- Genomics Products: DNA-conjugated antibodies and antibody cocktails for single-cell RNA sequencing applications, including the MultiPro Immune Profiling Cocktail.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard research use antibodies and proteins |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels9 records
Proteintech Group product offering
Product offeringCore offering
Proteintech Group manufactures and sells self-developed antibodies, recombinant proteins, ELISA kits, cytokines/growth factors, and nanobody-based reagents for life science research and cell/gene therapy applications. Its product lines span polyclonal and recombinant monoclonal antibodies (including Uni-rAb, Multi-rAb, FcZero-rAb), HumanKine human cell-expressed cytokines from RUO to cGMP grade, ChromoTek nanobody reagents (Nano-Traps, Chromobodies, Spot-Tag), and ELISA kits, kits/buffers for Western blot, IHC, flow cytometry, immunofluorescence and immunoprecipitation workflows.
Product overview
Proteintech Group is a global manufacturer of antibodies, proteins, nanobodies, and immunoassays for life science research. The portfolio centers on a comprehensive antibody platform (traditional polyclonal and recombinant monoclonal antibodies including the Uni-rAb and Multi-rAb platforms) complemented by HumanKine human cell-expressed cytokines and growth factors (available from RUO to cGMP grade), and ChromoTek nanobody-based reagents (including Nano-Traps, Chromobodies, and related VHH antibody products). The company also offers genomics products through its Proteintech Genomics division, including DNA-conjugated antibodies for single-cell RNA sequencing. Key enabling technologies include the ABCE recombinant antibody platform, Able AI search and advisory tool, and 3D Epitope Mapping. Services include custom antibody production, with cGMP manufacturing capabilities for cell and gene therapy applications.
Differentiator
Problem solved
Functional benefit
Brands
- Humankine: Human cell expressed cytokines and growth factors available from RUO to cGMP grade.
- ChromoTek
- CoraLite
- Able AI
- ABCE
- Uni-rAb
- Multi-rAb
Products and services
- Primary and Secondary Antibodies
Quantifiable outcome
- CiteAb Researchers' Choice Award 2026 (second consecutive year)
- +1 more outcomes
Companies that use Proteintech Group
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Proteintech Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature8 records
Proteintech Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Biocare MedicalcoreStrategic collaboration and co-development agreement to advance next-generation antibody solutions for modern pathology workflows. Combines Proteintech's antibody discovery and protein engineering capabilities with Biocare's diagnostic assay and immunohistochemistry expertise. Aims to accelerate development of high-performance antibody reagents for tissue-based diagnostics, translational research, and precision oncology applications including antibody-drug conjugates and companion diagnostics. Addresses industry-wide challenges related to antibody reproducibility and assay standardization as digital pathology adoption grows.
- 10x Genomics (Acquirer of Proteintech Genomics Division)minor10x Genomics acquired Proteintech Genomics, a division of Proteintech Group that developed high-plex proteomic solutions for single-cell and spatial biology applications. The deal included the Human Discovery Panel, the largest antibody-based single-cell protein panel compatible with 10x Genomics' Flex chemistry workflows. Transaction terms were not disclosed. Proteintech retains its core antibodies, proteins, and immunoassays business.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Proteintech Group competitors and assessment
Company assessmentDirect peers
- Cell Signaling Technology: Privately held manufacturer of research antibodies and reagents with strong brand among academic and pharma researchers; directly comparable to Proteintech in catalog breadth, application focus (WB, IHC, IF, FC), and recombinant antibody strategy.
- Abcam (Danaher): Global research antibody supplier acquired by Danaher in 2023; competes head-to-head with Proteintech in primary and secondary antibodies, recombinant antibodies, and immunoassays across academic and industrial customers.
- Bio-Techne (R&D Systems / Novus Biologicals): Public life science tools company housing R&D Systems (proteins, cytokines, ELISA kits) and Novus Biologicals (antibodies); directly overlaps with Proteintech's HumanKine, ELISA, and antibody product lines, with additional GMP reagent capabilities.
- Santa Cruz Biotechnology: Long-standing research antibody supplier covering a broad catalog of polyclonal, monoclonal, and conjugated antibodies for WB, IHC, IF, and ChIP; competes directly with Proteintech in academic research segments.
- Atlas Antibodies: Sweden-based antibody company spun out of the Human Protein Atlas, focused on highly validated antibodies for IHC, WB, and IF; competes with Proteintech on recombinant antibody quality and proteome coverage.
- Jackson ImmunoResearch: Specialty manufacturer of secondary antibodies and immunoreagents; directly comparable to Proteintech's secondary antibody portfolio and conjugated reagent offerings.
Broad incumbents
- Thermo Fisher Scientific (Life Sciences / Antibodies): Diversified life science tools giant offering antibodies, proteins, and immunoassays as part of a broader portfolio that includes instruments, reagents, and services; competes with Proteintech across most product categories but as one of many priorities.
- Bio-Rad Laboratories: Established life science research and clinical diagnostics company with antibody, protein, and immunoassay offerings; comparable to Proteintech in research reagent categories but operates a broader portfolio across instruments and clinical diagnostics.
- Miltenyi Biotec: Cell biology and cell therapy tools provider with antibody, reagent, and instrumentation offerings; overlaps with Proteintech on antibodies, magnetic cell separation, and GMP-grade reagents for cell and gene therapy workflows.
Emerging players
- GenScript: Global biotech offering custom antibody services, recombinant proteins, and cell therapy reagents alongside a research reagent catalog; comparable to Proteintech on custom services and cGMP proteins for cell and gene therapy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Proteintech Group social profiles
Digital presenceProteintech Group compliance and trust
Trust signalCompliance2 records
Proteintech Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Proteintech Group leadership team
Management profileNumber of profiles
Profiles1 record
Proteintech Group subsidiaries and ownership
Company hierarchySubsidiaries1 record
Proteintech Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Proteintech Group M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Proteintech Group
What does Proteintech Group do?
Proteintech Group manufactures and sells self-developed antibodies, recombinant proteins, ELISA kits, cytokines/growth factors, and nanobody-based reagents for life science research and cell/gene therapy applications. Its product lines span polyclonal and recombinant monoclonal antibodies (including Uni-rAb, Multi-rAb, FcZero-rAb), HumanKine human cell-expressed cytokines from RUO to cGMP grade, ChromoTek nanobody reagents (Nano-Traps, Chromobodies, Spot-Tag), and ELISA kits, kits/buffers for Western blot, IHC, flow cytometry, immunofluorescence and immunoprecipitation workflows.
Is Proteintech Group a public or private company?
Proteintech Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Proteintech Group founded?
Proteintech Group was founded in 2001. It employs 251 to 500 people.
Where is Proteintech Group based?
Proteintech Group is headquartered in Rosamond, United States, in the North America region.
How does Proteintech Group make money?
Six revenue lines are on record. Research Antibodies are the primary driver. The others are recombinant Proteins, ELISA Kits, nanobody-based Reagents, custom Antibody Services and genomics Products.
Who are Proteintech Group's main competitors?
Direct peers on record are Cell Signaling Technology, Abcam (Danaher), Bio-Techne (R&D Systems / Novus Biologicals), Santa Cruz Biotechnology, Atlas Antibodies and Jackson ImmunoResearch. Broad incumbents are Thermo Fisher Scientific (Life Sciences / Antibodies), Bio-Rad Laboratories and Miltenyi Biotec. GenScript is listed as an emerging player.
Does Proteintech Group have an API?
No public API is recorded for Proteintech Group.
What industry is Proteintech Group in?
Proteintech Group's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering). Its NAICS code is 325413 and its SIC code is 2835.